LIPOPROTEIN (A) LEVELS IN MONOGENIC VERSUS POLYGENIC HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Jain, A. [1 ]
Ewang-Emukowhate, M. [1 ]
Hoshi, N. [1 ]
Omosilade, M. [1 ]
Nair, D. R. [1 ]
机构：
[1] Royal Free Hosp, Dept Clin Biochem, Pond St, London NW32QG, England
来源：
ATHEROSCLEROSIS PLUS | 2021年 / 43卷
关键词：
Polygenic Hypercholesterolemia; Lipoprotein (a); Familial hypercholesterolemia;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] CHARACTERISTICS OF MONOGENIC VERSUS POLYGENIC FAMILIAL HYPOBETALIPOPROTEINEMIA
    Rimbert, A.
    Coulibaly, D.
    Marrec, M.
    Pichelin, M.
    Charriere, S.
    Peretti, N.
    Valero, R.
    Wargny, M.
    Carrie, A.
    Vanhoye, X.
    Farnier, P. A. Rollat
    Goxe, D.
    Degraef, G.
    Bigot-Corbel, E.
    Moulin, P.
    Cariou, B.
    Di Filippo, M.
    ATHEROSCLEROSIS, 2020, 315 : E4 - E4
  • [22] Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
    Trinder, Mark
    Francis, Gordon A.
    Brunham, Liam R.
    JAMA CARDIOLOGY, 2020, 5 (04) : 390 - 399
  • [23] Monogenic and polygenic causes of low high density lipoprotein cholesterol
    von Eckardstein, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 25 - 25
  • [24] LOW-DENSITY-LIPOPROTEIN RECEPTOR LEVELS AND THE RESPONSE TO DIETARY AND PHARMACOLOGICAL INTERVENTION IN POLYGENIC HYPERCHOLESTEROLEMIA
    JOVEN, J
    VILELLA, E
    MASANA, L
    ANSOLEAGA, J
    CLINICA CHIMICA ACTA, 1991, 197 (01) : 67 - 76
  • [25] GENETIC TESTING OF FAMILIAL HYPERCHOLESTEROLEMIA: MONOGENIC FORM AND POLYGENIC CONTRIBUTION TO CARDIOVASCULAR RISK
    Couvert, Philippe
    Giral, Philippe
    Boelle, Pierre-Yves
    Carreau, Valerie
    Beliard, Sophie
    Lacorte, Jean-Marc
    Lesnik, Philippe
    Paillard, Francois
    Valero, Rene
    Rotthier, Annelies
    Bruckert, Eric
    Carrie, Alain
    ATHEROSCLEROSIS, 2017, 263 : E94 - E94
  • [26] Lipoprotein (a), an additional risk factor for the occurrence of cardiovascular events in high-risk patient groups with monogenic familial hypercholesterolemia, polygenic familial hypercholesterolemia or type 2 diabetes
    del Marmol, Gregoire
    Aksel, Ysar
    Descamps, Olivier
    ACTA CARDIOLOGICA, 2020, 75 : 49 - 50
  • [27] EFFECT OF GEMFIBROZIL VERSUS LOVASTATIN ON INCREASED SERUM LIPOPROTEIN(A) LEVELS OF PATIENTS WITH HYPERCHOLESTEROLEMIA
    RAMIRES, JAF
    MANSUR, AP
    SOLIMENE, MC
    MARANHAO, R
    CHAMONE, D
    DALUZ, P
    PILEGGI, F
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 48 (02) : 115 - 120
  • [28] Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
    D'Erasmo, Laura
    Minicocci, Ilenia
    Di Costanzo, Alessia
    Pigna, Giovanni
    Commodari, Daniela
    Ceci, Fabrizio
    Montali, Anna
    Brancato, Francesca
    Stanca, Ilaria
    Nicolucci, Antonio
    Ascione, Andrea
    Galea, Nicola
    Carbone, Iacopo
    Francone, Marco
    Maranghi, Marianna
    Arca, Marcello
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (09):
  • [29] Monogenic hypercholesterolemia
    Topic, RZ
    Rukavina, AS
    PERIODICUM BIOLOGORUM, 2004, 106 (03) : 245 - 249
  • [30] LIPOPROTEIN(A) LEVELS IN A COHORT OF PRIMARY HYPERCHOLESTEROLEMIA
    Gutierrez Cortizo, E. N.
    Sanchez Ruiz-Granados, E.
    Mansilla Rodriguez, E.
    Bonet Estruch, E.
    Camacho Carrasco, A.
    Diaz Santos, M. A.
    Romero Jimenez, M. J.
    ATHEROSCLEROSIS, 2020, 315 : E144 - E144
12345